Crossmark

Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study

Published Online: 2020-09-16

Published Print: 2020-12

Authors

Sarao, Valentina

Veritti, Daniele

Lanzetta, Paolo https://orcid.org/0000-0003-3746-141X
License Information

Text and Data Mining valid from 2020-09-16

Version of Record valid from 2020-09-16
More Information

Article History

Received: 26 April 2020

Revised: 12 June 2020

Accepted: 14 July 2020

First Online: 16 September 2020

Compliance of ethical standard

:

: V. Sarao has acted as a consultant for Centervue; D. Veritti has acted as a consultant for Novartis and Roche; P. Lanzetta has acted as a consultant for Allergan, Bayer, Centervue, Novartis and Roche.

: General Data Protection Regulation (GDPR) compliance was maintained. Care of the patients in this study was in accordance with the Declaration of Helsinki.

Document is current